Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome

Objective Our objective was to investigate the concentration of plasma thrombopoietin (TPO) in patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS), as well as its relationship with patients' responses to recombined human TPO (rhTPO) therapy.

Bibliographic Details
Main Authors: Mengying Zhang, Gaochao Zhang, Fangfang Xu, Mengyuan Liu, Xifeng Dong, Weiwei Qi, Huaquan Wang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-09-01
Series:Global Medical Genetics
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1771456